LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
+3.22%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.6B
AUM Growth
+$807M
(+29%)
Cap. Flow
+$734M
Cap. Flow
% of AUM
20.42%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
467
New
156
Increased
40
Reduced
28
Closed
91
Top Buys
| 1 |
Apple
AAPL
|
$109M |
| 2 |
CVS Health
CVS
|
$96M |
| 3 |
Adobe
ADBE
|
$90.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$70.7M |
| 5 |
Microsoft
MSFT
|
$69.4M |
Top Sells
| 1 |
Kenvue
KVUE
|
$156M |
| 2 |
Vistra
VST
|
$144M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$121M |
| 4 |
General Motors
GM
|
$85M |
| 5 |
Honeywell
HON
|
$72.5M |
Sector Composition
| 1 | Healthcare | 38.37% |
| 2 | Technology | 18.29% |
| 3 | Consumer Discretionary | 9.42% |
| 4 | Financials | 7.94% |
| 5 | Energy | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Nu Holdings
NU
$71.2B
| $1.71M | 0.01% |
+143,743
| New | +$1.71M |
|
177
Citi Trends
CTRN
$313M
| $1.7M | 0.01% |
62,816
| – | – |
|
178
Post Holdings
POST
$5.88B
| $1.7M | 0.01% |
16,000
| – | – |
|
179
CytomX Therapeutics
CTMX
$376M
| $1.67M | 0.01% |
764,187
-329,734
| -30% | -$719K |
|
180
Newmont
NEM
$83.7B
| $1.65M | 0.01% |
+46,001
| New | +$1.65M |
|
181
Matrix Service
MTRX
$403M
| $1.63M | 0.01% |
125,178
| – | – |
|
182
SharkNinja
SN
$16.5B
| $1.6M | 0.01% |
25,705
+7,000
| +37% | +$436K |
|
183
On Holding
ONON
$14.9B
| $1.6M | 0.01% |
45,227
+15,000
| +50% | +$531K |
|
184
Janux Therapeutics
JANX
$1.44B
| $1.51M | 0.01% |
+40,000
| New | +$1.51M |
|
|
LBPH
185
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.48M | 0.01% |
68,555
+46,645
| +213% | +$1.01M |
|
186
Rallybio
RLYB
$25.4M
| $1.45M | 0.01% |
783,391
| – | – |
|
187
Alto Ingredients
ALTO
$90.6M
| $1.42M | 0.01% |
653,457
| – | – |
|
188
Louisiana-Pacific
LPX
$6.9B
| $1.38M | 0.01% |
+16,462
| New | +$1.38M |
|
189
Rekor Systems
REKR
$138M
| $1.37M | 0.01% |
598,900
| – | – |
|
190
Fulcrum Therapeutics
FULC
$414M
| $1.37M | 0.01% |
144,721
| – | – |
|
|
191
Honeywell
HON
$136B
| $1.36M | 0.01% |
6,623
-353,278
| -98% | -$72.5M |
|
192
Stoke Therapeutics
STOK
$1.13B
| $1.35M | 0.01% |
+100,000
| New | +$1.35M |
|
193
Werewolf Therapeutics
HOWL
$61.7M
| $1.3M | 0.01% |
201,236
+122,023
| +154% | +$791K |
|
194
AerCap
AER
$22B
| $1.3M | 0.01% |
15,000
| – | – |
|
195
ODDITY Tech
ODD
$3.52B
| $1.3M | 0.01% |
+30,000
| New | +$1.3M |
|
196
Corebridge Financial
CRBG
$18.1B
| $1.26M | 0.01% |
+43,981
| New | +$1.26M |
|
197
Veru
VERU
$49.4M
| $1.19M | 0.01% |
170,000
| – | – |
|
198
NRG Energy
NRG
$28.6B
| $1.17M | 0.01% |
+17,278
| New | +$1.17M |
|
199
Veeva Systems
VEEV
$44.7B
| $1.16M | 0.01% |
5,000
| – | – |
|
200
Backblaze
BLZE
$491M
| $1.15M | 0.01% |
112,672
| – | – |
|